Jpmorgan Chase & CO Iridex Corp Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Iridex Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 32 shares of IRIX stock, worth $44. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 32
-0.0%
Holding current value
$44
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IRIX
# of Institutions
31Shares Held
3.25MCall Options Held
500Put Options Held
61.3K-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$1.39 Million5.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA561KShares$779,9230.0% of portfolio
-
Amh Equity LTD461KShares$640,5121.39% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny405KShares$562,8940.0% of portfolio
-
Geode Capital Management, LLC Boston, MA129KShares$179,4370.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $22.2M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...